A new study provides strong evidence supporting the use of dolutegravir and TAF-emtricitabine for second-line antiretroviral ...

Discover a study that found that young adults had the highest UV exposure and sunburn rates, and were least likely to use ...

A once-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with ...

A phase 3 clinical trial reports that nerandomilast was associated with a smaller decline in forced vital capacity in ...

Discover a study that also highlighted that treatment intensification with enzalutamide benefited patients regardless of ...